Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedMay 13, 2025
DataAggregated Company Financials
Companies4
  • 7D-0.3%
  • 3M-6.3%
  • 1Y-21.8%
  • YTD4.3%

The Life Sciences industry has stayed flat over the last week. As for the longer term, the industry has declined 25% in the last year. Looking forward, earnings are forecast to grow by 28% annually.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 13 May 2025€22.0b€7.3b€101.5m29.5x216.3x3x
Thu, 10 Apr 2025€17.0b€7.1b€156.5m22.5x108.7x2.4x
Sat, 08 Mar 2025€21.9b€7.1b€156.5m27.9x140.1x3.1x
Mon, 03 Feb 2025€24.8b€7.1b€169.8m23.7x146x3.5x
Wed, 01 Jan 2025€21.1b€7.1b€169.8m25.3x124.2x3x
Fri, 29 Nov 2024€22.1b€7.1b€170.5m27.3x129.8x3.1x
Sun, 27 Oct 2024€23.9b€7.1b€171.2m31.5x139.5x3.4x
Tue, 24 Sep 2024€23.5b€7.1b€172.8m30.5x135.8x3.3x
Thu, 22 Aug 2024€23.9b€7.0b€157.1m35.1x152x3.4x
Sat, 20 Jul 2024€23.0b€7.0b€237.1m34.7x97.1x3.3x
Mon, 17 Jun 2024€24.3b€7.0b€333.3m29.7x72.9x3.5x
Wed, 15 May 2024€28.7b€7.0b€340.1m35.6x84.4x4.1x
Fri, 12 Apr 2024€33.0b€7.1b€385.4m38.2x85.6x4.6x
Sun, 10 Mar 2024€33.9b€7.1b€384.5m36.2x88.2x4.8x
Tue, 06 Feb 2024€31.8b€7.3b€516.3m36.7x61.7x4.4x
Thu, 04 Jan 2024€32.0b€7.3b€507.1m33.8x63.1x4.4x
Sat, 02 Dec 2023€28.5b€7.3b€507.1m30.4x56.1x3.9x
Mon, 30 Oct 2023€24.4b€6.4b€356.1m36.6x68.6x3.8x
Wed, 27 Sep 2023€26.8b€6.6b€498.1m38.4x53.9x4.1x
Fri, 25 Aug 2023€29.4b€6.6b€425.8m42.9x69x4.5x
Sun, 23 Jul 2023€29.5b€6.8b€496.6m38.6x59.4x4.4x
Tue, 20 Jun 2023€26.3b€6.7b€487.3m37.3x54x3.9x
Thu, 18 May 2023€27.5b€6.7b€487.3m37.5x56.5x4.1x
Sat, 15 Apr 2023€30.9b€6.8b€595.6m34.9x51.9x4.6x
Mon, 13 Mar 2023€30.5b€6.7b€594.3m34.9x51.3x4.6x
Wed, 08 Feb 2023€34.3b€6.5b€447.4m42x76.6x5.3x
Fri, 06 Jan 2023€29.0b€6.5b€447.4m35.5x64.7x4.5x
Sun, 04 Dec 2022€29.4b€6.5b€447.4m36.2x65.6x4.5x
Tue, 01 Nov 2022€27.7b€6.4b€629.0m45.5x44x4.3x
Thu, 29 Sep 2022€27.4b€6.2b€573.0m50.1x47.8x4.4x
Sat, 27 Aug 2022€5.7b€2.3b€84.0m1263.2x68.2x2.5x
Mon, 25 Jul 2022€6.5b€2.3b€171.9m37.3x37.9x2.9x
Wed, 22 Jun 2022€6.3b€2.2b€173.3m35.6x36.2x2.8x
Fri, 20 May 2022€6.5b€2.2b€173.3m36.5x37.2x2.9x
Price to Earnings Ratio

37.2x


Total Market Cap: €6.5bTotal Earnings: €173.3mTotal Revenue: €2.2bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 82x202320242025
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 210x which is higher than its 3-year average PE of 81.5x.
  • The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 2.9x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 49% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market0.70%
Healthcare0.98%
Life Sciences-0.31%
Clinical Research and Equipment-0.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1SXP SCHOTT Pharma KGaA€26.253.8%
+€143.1m
-28.7%PE29.5x
GXI Gerresheimer€62.051.8%
+€38.0m
-36.8%PE27.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.